FARSA and colorectal carcinoma: In conclusion, FARSA-AS1 was upregulated in CRC cells and facilitated CRC progression by upregulating SOX9 and FARSA. This discovery provides a helpful theoretical basis for the exploration of effective CRC therapeutic strategies.